| Followers | 5 |
| Posts | 503 |
| Boards Moderated | 0 |
| Alias Born | 10/08/2020 |
Wednesday, March 22, 2023 1:05:17 PM
Bullish
Recent SANA News
- Sana Biotechnology to Present at June 2026 Investor Conferences • GlobeNewswire Inc. • 05/27/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:06:25 PM
- Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility • GlobeNewswire Inc. • 05/15/2026 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/11/2026 08:17:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/11/2026 08:10:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/11/2026 08:08:24 PM
- Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates • GlobeNewswire Inc. • 05/11/2026 08:05:00 PM
- Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference • GlobeNewswire Inc. • 05/05/2026 08:05:00 PM
- Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting • GlobeNewswire Inc. • 04/27/2026 08:30:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/24/2026 10:30:12 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/24/2026 10:25:18 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/24/2026 10:20:43 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/24/2026 10:00:28 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/13/2026 09:04:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 08:10:07 PM
- Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451 • GlobeNewswire Inc. • 04/13/2026 08:05:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 08:15:24 PM
- Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression • GlobeNewswire Inc. • 03/13/2026 01:00:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/03/2026 10:20:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 09:11:19 PM
- Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates • GlobeNewswire Inc. • 03/03/2026 09:05:00 PM
- Sana Biotechnology to Present at March 2026 Investor Conferences • GlobeNewswire Inc. • 02/23/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 02:07:30 PM
- Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer • GlobeNewswire Inc. • 02/17/2026 02:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/21/2026 05:30:36 PM
